Clinical Trials Logo

Aging clinical trials

View clinical trials related to Aging.

Filter by:

NCT ID: NCT00520910 Completed - Aging Clinical Trials

Efficacy of Polypodium Leucotomos Extract Decreasing UVA Premutagenic and Photoaging Markers

Start date: August 2007
Phase: Phase 2
Study type: Interventional

With this study, the investigators will like to determine if taking a dose of the study medication, called Polypodium leucotomos (PL), prevents some of the changes in the skin caused by the adverse effects of UVA, a type of ultraviolet light.

NCT ID: NCT00506428 Recruiting - Aging Clinical Trials

Effects of Chronic Sleep Restriction in Young and Older People

Start date: December 2006
Phase: N/A
Study type: Interventional

The purpose of this study is to examine the consequences of chronic sleep restriction on nighttime sleep, daytime alertness, performance and memory functions, and metabolic and cardiovascular function, and to determine if the consequences of chronic sleep restriction differ between healthy young and older adults.

NCT ID: NCT00478439 Terminated - Aging Clinical Trials

Investigation of Macular Pigment Augmentation on Dark Adaptation

Start date: December 2007
Phase: Phase 4
Study type: Interventional

The study will evaluate whether taking a nutritional supplement designed to increase macular pigment in the eye can improve a person's ability to adjust to darkness. Patients will be assigned to take either a placebo or nutritional supplement for 8 months. Vision will be assessed at baseline, 4 months, and 8 months.

NCT ID: NCT00474279 Completed - Aging Clinical Trials

Effects of an Oral GH Secretagogue (MK-677) on Body Composition and Functional Ability of Older Adults

MOT089
Start date: July 1998
Phase: Phase 1/Phase 2
Study type: Interventional

The purpose of this study is to determine whether treatment of healthy older men and women with oral MK-677 for 12 months will enhance pulsatile GH release and increase mean GH and IGF-I concentrations into the range of young adults and will have favorable effects on body composition and functional ability on older adults.

NCT ID: NCT00472823 Completed - Aging Clinical Trials

Vitamin D Supplementation in Older Women

VIDOS
Start date: April 2007
Phase: N/A
Study type: Interventional

The purpose of this study is to examine the effects of several doses of vitamin D on hormones related to bone, calcium absorption, bone density and muscle strength.

NCT ID: NCT00462722 Completed - Aging Clinical Trials

Myogenic and Osteogenic Responses to eXercise and Ibuprofen

MOXI
Start date: July 2007
Phase: N/A
Study type: Interventional

The purpose of this study is to determine if the use of ibuprofen blocks the benefits of exercise to build bone and muscle mass.

NCT ID: NCT00459589 Completed - Cancer Clinical Trials

Nutritional Intervention in Geriatric Oncology

INOGAD
Start date: April 2007
Phase: N/A
Study type: Interventional

Older patients with cancer are poorly treated or not treated at all. A previous study in the south west of France (364 patients) showed that patients receiving chemotherapy had short survival times which strongly depended on nutritional status. In this study, the researchers would like to evaluate if individual dietician follow-up at each cycle of chemotherapy increases survival of patients at risk of undernutrition.

NCT ID: NCT00455741 Completed - Aging Clinical Trials

Postmenopausal Women Estrogen and Progesterone Infusion

Start date: November 2000
Phase: Phase 1/Phase 2
Study type: Interventional

The purpose of the study is to study the effects of aging, estrogen and progesterone on the brain. Specifically, we want to look at how the hypothalamus and pituitary (two small glands in the brain) respond to estrogen. The pituitary gland is controlled by the hypothalamus. The hypothalamus secretes GnRH (Gonadotropin-Releasing Hormone) that signals the pituitary to secrete the reproductive hormones, LH (Luteinizing Hormone) and FSH (Follicle Stimulating Hormone). These hormones act on the ovaries and signal the ovaries to produce estrogen and progesterone. Estrogen in the bloodstream then acts on the brain to modulate this system with changes in LH and FSH. Early changes associated with low levels of estrogen are inhibitory (estrogen negative feedback) while higher levels of estrogen (such as those present when a follicle in the ovary is ready to ovulate) stimulate LH to cause ovulation (positive feedback). This study will determine: 1) hypothalamic and pituitary levels of glucose uptake (as a measure of brain metabolic activity) at baseline and in association with estrogen negative feedback on LH (24 hr) and estrogen positive feedback on LH (72 hr); and 2) the effect of aging on estrogen feedback on LH, assessing negative feedback (nadir ~ 24 hr) and positive feedback (peak between 72 and 96 hr).

NCT ID: NCT00438724 Recruiting - Alzheimer Disease Clinical Trials

Couples Coping With Alzheimer's Disease

Start date: November 2004
Phase: N/A
Study type: Interventional

The purpose of this study is to test the efficacy of a new couples counseling intervention for people recently diagnosed with early Alzheimer's disease and their spouses. The study hypothesis is that counseling the couple shortly after the diagnosis, and while the functional impact of the illness is still relatively mild, will have a significant impact on their ability to provide support for each other.

NCT ID: NCT00438347 Completed - Aging Clinical Trials

Influence of Fitness on Brain and Cognition

Start date: April 2006
Phase: N/A
Study type: Observational

The purpose of this study is to examine the effect of aerobic fitness training on human cognition, brain structure, and brain function of older adults.